Abstract
Background: Prediabetes is a reversible condition before the onset of Type 2 Diabetes Mellitus. Untreated condition of prediabetes will develop into diabetes and its complications. The prevalence of prediabetes has been emerging worldwide and has a considerable socioeconomic impact. The current study reviews the roles of early detection, educational models, life modification, and prophylaxis of individuals with prediabetes in preventing the progression of prediabetes into Type 2 Diabetes Mellitus and complications in the future.
Methods: This study included published articles from several electronic databases. The obtained articles were limited to March 2023. Articles that were not open access and not in Indonesian or English were excluded. The protocol for this study used the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020.
Results: Of 39627 articles, 39601 were excluded due to duplication and did not meet the eligibility criteria. At the final, there were 26 articles that were eligible for systematic review.
Conclusion: Prevention of the development of prediabetes into diabetes is essential. A comprehensive understanding and training on intensive lifestyle modification protocols from local and national experts in diabetes prevention through digital-based education models and linguistically and culturally approach can be considered. Intensive lifestyle modification and pharmacological approaches may improve the outcome. Regular monitoring of glycemic control is also important for early diagnosis of diabetes, especially in patients with special conditions.
[1]
Khan R, Chua Z, Tan J, Yang Y, Liao Z, Zhao Y. From pre-diabetes to diabetes: Diagnosis, treatments and translational research. Medicina 2019; 55(9): 546.
[http://dx.doi.org/10.3390/medicina55090546] [PMID: 31470636]
[http://dx.doi.org/10.3390/medicina55090546] [PMID: 31470636]
[2]
Marciano L, Camerini AL, Schulz PJ. The role of health literacy in diabetes knowledge, self-care, and glycemic control: A meta-analysis. J Gen Intern Med 2019; 34(6): 1007-17.
[http://dx.doi.org/10.1007/s11606-019-04832-y] [PMID: 30877457]
[http://dx.doi.org/10.1007/s11606-019-04832-y] [PMID: 30877457]
[3]
Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119.
[http://dx.doi.org/10.1016/j.diabres.2021.109119] [PMID: 34879977]
[http://dx.doi.org/10.1016/j.diabres.2021.109119] [PMID: 34879977]
[4]
Al-Lawati JA. Diabetes Mellitus: A local and global public health emergency! Oman Med J 2017; 32(3): 177-9.
[http://dx.doi.org/10.5001/omj.2017.34] [PMID: 28584596]
[http://dx.doi.org/10.5001/omj.2017.34] [PMID: 28584596]
[5]
The Ministry of Health of the Republic of Indonesia. InfoDATin 2020 Diabetes Melitus. Pusdatin 2020.
[6]
Hidayat B, Ramadani RV, Rudijanto A, Soewondo P, Suastika K, Siu Ng JY. Direct medical cost of type 2 diabetes mellitus and its associated complications in Indonesia. Value Health Reg Issues 2022; 28: 82-9.
[http://dx.doi.org/10.1016/j.vhri.2021.04.006] [PMID: 34839111]
[http://dx.doi.org/10.1016/j.vhri.2021.04.006] [PMID: 34839111]
[7]
American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care 2015; 38 (Suppl. 1): S8-S16.
[http://dx.doi.org/10.2337/dc15-S005] [PMID: 25537714]
[http://dx.doi.org/10.2337/dc15-S005] [PMID: 25537714]
[8]
Hostalek U. Global epidemiology of prediabetes-present and future perspectives. Clin Diabetes Endocrinol 2019; 5(1): 5.
[http://dx.doi.org/10.1186/s40842-019-0080-0] [PMID: 31086677]
[http://dx.doi.org/10.1186/s40842-019-0080-0] [PMID: 31086677]
[9]
Echouffo-Tcheugui JB, Selvin E. Prediabetes and what it means: The epidemiological evidence. Annu Rev Public Health 2021; 42(1): 59-77.
[http://dx.doi.org/10.1146/annurev-publhealth-090419-102644] [PMID: 33355476]
[http://dx.doi.org/10.1146/annurev-publhealth-090419-102644] [PMID: 33355476]
[10]
Moradpour F, Rezaei S, Piroozi B, et al. Prevalence of prediabetes, diabetes, diabetes awareness, treatment, and its socioeconomic inequality in west of Iran. Sci Rep 2022; 12(1): 17892.
[http://dx.doi.org/10.1038/s41598-022-22779-9] [PMID: 36284227]
[http://dx.doi.org/10.1038/s41598-022-22779-9] [PMID: 36284227]
[11]
Yip W, Sequeira I, Plank L, Poppitt S. Prevalence of pre-diabetes across ethnicities: A review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for classification of dysglycaemia. Nutrients 2017; 9(11): 1273.
[http://dx.doi.org/10.3390/nu9111273] [PMID: 29165385]
[http://dx.doi.org/10.3390/nu9111273] [PMID: 29165385]
[12]
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1C test in diagnosis and prognosis of diabetic patients. Biomark Insights 2016; 11: BMI.S38440.
[http://dx.doi.org/10.4137/BMI.S38440] [PMID: 27398023]
[http://dx.doi.org/10.4137/BMI.S38440] [PMID: 27398023]
[13]
Thankappan KR, Sathish T, Tapp RJ, et al. A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program. PLoS Med 2018; 15(6): e1002575.
[http://dx.doi.org/10.1371/journal.pmed.1002575] [PMID: 29874236]
[http://dx.doi.org/10.1371/journal.pmed.1002575] [PMID: 29874236]
[14]
Davies MJ, Gray LJ, Troughton J, et al. A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: The Let’s Prevent Diabetes cluster randomised controlled trial. Prev Med 2016; 84: 48-56.
[http://dx.doi.org/10.1016/j.ypmed.2015.12.012] [PMID: 26740346]
[http://dx.doi.org/10.1016/j.ypmed.2015.12.012] [PMID: 26740346]
[15]
Hu Z, Qin L, Xu H. One-year results of a synthetic intervention model for the primary prevention of T2D among elderly individuals with prediabetes in Rural China. Int J Environ Res Public Health 2017; 14(4): 417.
[http://dx.doi.org/10.3390/ijerph14040417] [PMID: 28420105]
[http://dx.doi.org/10.3390/ijerph14040417] [PMID: 28420105]
[16]
Juul L, Andersen VJ, Arnoldsen J, Maindal HT. Effectiveness of a brief theory-based health promotion intervention among adults at high risk of type 2 diabetes: One-year results from a randomised trial in a community setting. Prim Care Diabetes 2016; 10(2): 111-20.
[http://dx.doi.org/10.1016/j.pcd.2015.07.002] [PMID: 26259517]
[http://dx.doi.org/10.1016/j.pcd.2015.07.002] [PMID: 26259517]
[17]
Fischer HH, Fischer IP, Pereira RI, et al. Text message support for weight loss in patients with prediabetes: A randomized clinical trial. Diabetes Care 2016; 39(8): 1364-70.
[http://dx.doi.org/10.2337/dc15-2137] [PMID: 26861922]
[http://dx.doi.org/10.2337/dc15-2137] [PMID: 26861922]
[18]
Ramachandran A, Snehalatha C, Ram J, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: A prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 2013; 1(3): 191-8.
[http://dx.doi.org/10.1016/S2213-8587(13)70067-6] [PMID: 24622367]
[http://dx.doi.org/10.1016/S2213-8587(13)70067-6] [PMID: 24622367]
[19]
Katula JA, Dressler EV, Kittel CA, et al. Effects of a digital diabetes prevention program: An RCT. Am J Prev Med 2022; 62(4): 567-77.
[http://dx.doi.org/10.1016/j.amepre.2021.10.023] [PMID: 35151522]
[http://dx.doi.org/10.1016/j.amepre.2021.10.023] [PMID: 35151522]
[20]
Wong CKH, Fung CSC, Siu SC, et al. A short message service (SMS) intervention to prevent diabetes in Chinese professional drivers with pre-diabetes: A pilot single-blinded randomized controlled trial. Diabetes Res Clin Pract 2013; 102(3): 158-66.
[http://dx.doi.org/10.1016/j.diabres.2013.10.002] [PMID: 24466598]
[http://dx.doi.org/10.1016/j.diabres.2013.10.002] [PMID: 24466598]
[21]
Wong CKH, Jiao FF, Siu SC, et al. Cost-Effectiveness of a short message service intervention to prevent type 2 Diabetes from impaired glucose tolerance. J Diabetes Res 2016; 2016: 1-8.
[http://dx.doi.org/10.1155/2016/1219581] [PMID: 26798647]
[http://dx.doi.org/10.1155/2016/1219581] [PMID: 26798647]
[22]
Sakane N, Kotani K, Takahashi K, et al. Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial. BMJ Open 2015; 5(8): e007316.
[http://dx.doi.org/10.1136/bmjopen-2014-007316] [PMID: 26289448]
[http://dx.doi.org/10.1136/bmjopen-2014-007316] [PMID: 26289448]
[23]
Yeh MC, Heo M, Suchday S, et al. Translation of the diabetes prevention program for diabetes risk reduction in Chinese immigrants in New York City. Diabet Med 2016; 33(4): 547-51.
[http://dx.doi.org/10.1111/dme.12848] [PMID: 26179569]
[http://dx.doi.org/10.1111/dme.12848] [PMID: 26179569]
[24]
Glechner A, Keuchel L, Affengruber L, et al. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis. Prim Care Diabetes 2018; 12(5): 393-408.
[http://dx.doi.org/10.1016/j.pcd.2018.07.003] [PMID: 30076075]
[http://dx.doi.org/10.1016/j.pcd.2018.07.003] [PMID: 30076075]
[25]
Tran VD, James AP, Lee AH, Jancey J, Howat PA, Thi Phuong Mai L. Effectiveness of a community-based physical activity and nutrition behavior intervention on features of the metabolic syndrome: A cluster-randomized controlled trial. Metab Syndr Relat Disord 2017; 15(2): 63-71.
[http://dx.doi.org/10.1089/met.2016.0113] [PMID: 27997282]
[http://dx.doi.org/10.1089/met.2016.0113] [PMID: 27997282]
[26]
Ely EK, Gruss SM, Luman ET, et al. A national effort to prevent type 2 diabetes: Participant-level evaluation of CDC’s National diabetes prevention program. Diabetes Care 2017; 40(10): 1331-41.
[http://dx.doi.org/10.2337/dc16-2099] [PMID: 28500215]
[http://dx.doi.org/10.2337/dc16-2099] [PMID: 28500215]
[27]
Terathongkum S, Wangpitipanit S, Kraithaworn P, et al. A community-based lifestyle modification for prevention diabetes in pre-diabetes: A quasi-experimental study. J Med Assoc Thai 2018; 101: 297-304.
[28]
Aguiar EJ, Morgan PJ, Collins CE, Plotnikoff RC, Young MD, Callister R. Efficacy of the type 2 Diabetes prevention using lifestyle education program RCT. Am J Prev Med 2016; 50(3): 353-64.
[http://dx.doi.org/10.1016/j.amepre.2015.08.020] [PMID: 26526160]
[http://dx.doi.org/10.1016/j.amepre.2015.08.020] [PMID: 26526160]
[29]
Sampson M, Clark A, Bachmann M, et al. Effects of the Norfolk diabetes prevention lifestyle intervention (NDPS) on glycaemic control in screen-detected type 2 diabetes: A randomised controlled trial. BMC Med 2021; 19(1): 183.
[http://dx.doi.org/10.1186/s12916-021-02053-x] [PMID: 34407811]
[http://dx.doi.org/10.1186/s12916-021-02053-x] [PMID: 34407811]
[30]
Alfayez OM, Alsallum AA, Aljabri AF, et al. The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia. Front Public Health 2022; 10: 989072.
[http://dx.doi.org/10.3389/fpubh.2022.989072] [PMID: 36159298]
[http://dx.doi.org/10.3389/fpubh.2022.989072] [PMID: 36159298]
[31]
Man B, Schwartz A, Pugach O, Xia Y, Gerber B. A clinical diabetes risk prediction model for prediabetic women with prior gestational diabetes. PLoS One 2021; 16(6): e0252501.
[http://dx.doi.org/10.1371/journal.pone.0252501] [PMID: 34170930]
[http://dx.doi.org/10.1371/journal.pone.0252501] [PMID: 34170930]
[32]
Herman WH, Edelstein SL, Ratner RE, et al. Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. Am J Manag Care 2013; 19(3): 194-202.
[PMID: 23544761]
[PMID: 23544761]
[33]
O’Brien MJ, Perez A, Scanlan AB, et al. PREVENT-DM comparative effectiveness trial of lifestyle intervention and metformin. Am J Prev Med 2017; 52(6): 788-97.
[http://dx.doi.org/10.1016/j.amepre.2017.01.008] [PMID: 28237635]
[http://dx.doi.org/10.1016/j.amepre.2017.01.008] [PMID: 28237635]
[34]
Lee CH, Shih AZL, Woo YC, et al. Optimal cut-offs of Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) to identify dysglycemia and type 2 Diabetes Mellitus: A 15-year prospective study in Chinese. PLoS One 2016; 11(9): e0163424.
[http://dx.doi.org/10.1371/journal.pone.0163424] [PMID: 27658115]
[http://dx.doi.org/10.1371/journal.pone.0163424] [PMID: 27658115]
[35]
Welsh C, Welsh P, Celis-Morales CA, et al. Glycated hemoglobin, prediabetes, and the links to cardiovascular disease: Data from UK Biobank. Diabetes Care 2020; 43(2): 440-5.
[http://dx.doi.org/10.2337/dc19-1683] [PMID: 31852727]
[http://dx.doi.org/10.2337/dc19-1683] [PMID: 31852727]
[36]
Danese E, Montagnana M, Nouvenne A, Lippi G. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes. J Diabetes Sci Technol 2015; 9(2): 169-76.
[http://dx.doi.org/10.1177/1932296814567227] [PMID: 25591856]
[http://dx.doi.org/10.1177/1932296814567227] [PMID: 25591856]
[37]
Ake A, Saraswati MR, Widiana IGR. Glycated albumin as a marker of glycemic control in type 2 diabetes mellitus patients. Udayana J Internal Med 2017; 1(1): 1-7.
[http://dx.doi.org/10.36216/jpd.v1i1.10]
[http://dx.doi.org/10.36216/jpd.v1i1.10]
[38]
Chume FC, Kieling MH, Correa Freitas PA, Cavagnolli G, Camargo JL. Glycated albumin as a diagnostic tool in diabetes: An alternative or an additional test? PLoS One 2019; 14(12): e0227065.
[http://dx.doi.org/10.1371/journal.pone.0227065] [PMID: 31891628]
[http://dx.doi.org/10.1371/journal.pone.0227065] [PMID: 31891628]
